loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Open ICICI
3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

+91

BLOG

Glenmark has launched Sugammadex Injection in various strengths

ICICIdirect Research 29 Jul 2026 DISCLAIMER

News: Glenmark has launched Sugammadex Injection in various strengths (200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials) in the US. This injection is used in general anaesthesia. It is a generic version of BRIDION®2 Injection, owned by MSD, US. According to IQVIA ® sales data for the 12-month period ending May 2026, the RIDION® Injection, 100 mg/mL market3 achieved annual sales of approximately $1.6 billion. 

View: According to the USFDA generics data base, there are significant other generic players who have filed for the same. That said, given the size of the opportunity, this can be a good addition for Glenmark to strengthen its US portfolio especially in the hospitals space.

Impact: Positive

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere